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The  surface  of the  immunoglobulin  structure  plays  a  multifunctional  role 
within  the  immune  network.  The  variable  structures  of antibodies  express  a 
large repertoire of idiotypic specificities (idiotopes) and are also responsible for 
the vast diversity of different binding sites (paratopes). Crystallographic analyses 
of antibodies  have identified  V  regions that  form a  binding site or pocket for 
binding with antigen  (1).  The sequence regions that participate in the antigen- 
binding site have been correlated closely with the most variable sequence regions 
of the  domain,  and  were  described  as  complementarity-determining  regions 
(CDR) (2).  For communication with antibodies and receptors of immunocompe- 
tent cells, the Ig surface has developed another variable repertoire that expresses 
the diversity of idiotopes. Very little is known about the structural correlates of 
idiotypic determinants except that they must be accessible for antibodies to bind 
to.  This  implies  that  idiotopes are autoantigens,  as they are recognized as self 
antigens by the immune system (3). The size of the idiotope repertoire produces 
the statistical  necessity that  the shapes of other structures are mimicked.  This 
stereochemical mimicry generates what immunologists call internal  antigens  or 
homobodies (4, 5). Since the expression of idiotopes is, at least in part, made by 
an independent topographical area of the Ig surface (6), it should be possible for 
the same Ig structure to possess idiotope and paratope of complementary config- 
uration.  Mimicry of Ig determinants by idiotopes has been described recently by 
Bona and colleagues (7), and by Chen and coworkers (8). The term epibody was 
developed to signify the presence of an antibody recognizing  both an idiotope 
and an epitope on the original antigen.  In their example, the antigenic determi- 
nant mimicked by an idiotypic determinant may be the target for an antiidiotypic 
antibody (epibody). Herein,  we describe an antibody that  mimicks the antigen 
for its own paratope site. The specificity of the antibody is for phosphorylcholine 
(PC),  and  PC  is  mimicked  and  expressed  as  idiotope  by the  same  antibody. 
Coexpression  by  the  same  molecule  of paratopes  and  idiotopes  that  possess 
complementary structures may have profound implications for the understanding 
of the  network  concept  (8),  the  role  in  autoimmunity  (9),  and  the  design  of 
idiotype vaccines (10). 
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Materials and  Methods 
Mice.  Athymic BALB/c nu/nu mice, 6 wk old, were obtained from our own breeding 
colony.  Originally  these  mice  were  obtained  from the  National  Institutes  of Health, 
Bethesda, MD. 
Myeloma and  Hybridoma Proteins.  Myeloma  cell  lines  TEPC15  (T15),  MOPC167 
(M167),  MOPC603  (M603),  and  MOPC (M511)  were obtained from Litton  Bionetics, 
Kensington, MD, and were purified from ascitic fluid by PC-Sepharose column. Hybri- 
doma cell lines HPCGI 1 and HPCG12 were gifts from Dr. P. Gearhart, Johns Hopkins 
University,  Baltimore,  MD,  and  were  purified  from  ascitic  fluid  on  a  PC-Sepharose 
column. H PCG 13 and HPCG 14 hybridoma proteins were gifts from Dr. P. Gearhart (11). 
The anti-T 15 hybridoma F6-3 was prepared in our laboratory (12) and was purified on 
T 15-Sepharose column. The anti-M 167 hybridoma 4F1  was prepared in our laboratory 
and was purified on M 167-Sepharose column. The anti-TNP myeloma proteins MOPC315 
(M315) and MOPC460 (M460) were purified on TNP-Sepharose column, mAb 11E7-1 
was purified from ascites by affinity chromatography on T15-Sepharose column or PC- 
Sepharose column. 
Immunization and Fusion.  Athymic BALB/c nude mice were primed with  100 ~g i.p. 
of T15  IFA  three  times  at  3-wk  intervals.  3  d  after  the  last  immunization,  splenic 
lymphocytes were fused with P3-X63Ag8.653  myeloma cells,  and hybrids were selected 
in the HAT medium. Culture supernatants were tested by ELISA. One clone,  11E7, an 
IgM  K-producing hybridoma,  was  selected,  subcloned  twice  by limiting dilutions,  ex- 
panded in tissue culture, and then carried as ascitic tumor in BALB/c mice. 
ELISA.  For hybridoma screening,  96-well  microtiter plates (Becton  Dickinson  and 
Co., Oxnard,  CA) were coated for 18 h  with 0.1  ml of purified T15 (2 #g/ml) in PBS, 
washed three times, and incubated for 1 h with 1% BSA in PBS.  After washing, 20 ~1 of 
culture supernatant was added  to each well, with 80/~1  of 1%  BSA in borate-buffered 
saline. After washing, alkaline phosphatase-coupled goat anti-mouse IgG and IgM (South- 
ern Biotechnology Associates, Birmingham, AL) were used to detect antibodies binding 
to T15-coated plates. Substrate was added,  and the OD at 405  nm was measured.  For 
further details on other assays, see legends for figures. 
RIA.  Microtiter plates were coated for  18  h  with 0.1  ml of purified antibodies (10 
t~g/ml) or PCT-BSA (2 ~g/ml) in PBS, washed three times, and incubated for 2 h with 1% 
BSA in PBS. After washing, ~SI-labelled 11 E7-1 was added and incubated for 18 h. After 
incubation, the wells were extensively washed and the bound radioactivity of individual 
wells was determined in a gamma counter (Packard Instrument Co., Downers Grove, IL). 
Tests were done in quadruplicate. 
lmmunoblotting.  The binding of the  125I-labelled  11E7-1  to different antibodies and 
PC-BSA was tested by immunobiot. Nitrocellulose papers (Bio-Rad Laboratories, Rich- 
mond, CA) were loaded with 5/~1 of various antibodies (I mg/ml) or PCv-BSA (0.2 mg/ml), 
dried, and blocked for 1 h with 5% BSA in 50 mM Tris. The nitrocellulose sheets were 
then incubated for 3 h at room temperature with 5% BSA/50 mM Tris containing '~sI- 
labelled 11E7-1  (10 ~ cpm/ml) in the absence or presence of PC (10  -s M). After incubation, 
the nitrocellulose sheets were extensively washed, dried, and exposed to Kodak XAR-5 
film at -70°C for 3 h. 
Results 
Dual  Binding  to  PC and  T15.  A  hybridoma  antibody  was  isolated  from  a 
fusion  of  BALB/c  nude  mice  that  were  immunized  with  the  T15  myeloma 
protein.  T 15  is a  PC-binding  mye|oma and expresses the dominant  idiotype in 
the response of BALB/c mice to immunization with PC antigens (13). The 11E7 
hybridoma  was  selected  for  binding  to  insolubilized  T15  using  an  ELISA. 
Surprisingly, supernatant of 11 E7 also bound to insolubilized PC-BSA.  11 E7 was 
recloned twice, and the subclone  11E7-1  was used throughout this study. In Fig. 
1, the dual binding to PC and T 15-coated plates in ELISA are shown using the KANG  AND  KOHLER  789 
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FIGURE  1.  Binding profile of llE7-1  to PC-BSA and T15  using culture supernatant. The 
microtiter plates were coated for  18 h  with  100 #l/well of T15 (2 #g/ml) or  100 #l/well of 
PCT-BSA (2 #g/ml) in PBS, washed three times, and incubated for 1 h  with 1% BSA in PBS. 
After washing three times, culture supernatant in 1% BSA/0.05% Tween 20/borate-buffered 
saline solution  was  added.  Enzyme-coupled  goat  anti-mouse  IgM  was  used  for  detecting 
antibody binding to microtiter plates.  After washing three times, color was developed with 
substrate, and the OD at 405 nm was measured. 
culture supernatant of 11E7-1. As serial dilutions of supernatant are added, the 
binding to PC-BSA decreases while the binding to T15-coated plates increases. 
As  control,  no  binding  to  M167  plates  is  observed  with  any  dilution.  These 
results indicate that the I 1E7-1 hybridoma has a dual specificity for PC and T15. 
Consequently, it should be possible to purify the antibody by affinity chromatog- 
raphy  over  either  PC  immunoabsorbent  or  T15  immunoabsorbent,  l lE7-1 
ascites was raised in  BALB/c, passed over PC-Sepharose,  and eluted with  10  -3 
M  PC (14).  11E7-1  was also adsorbed to T15-Sepharose and eluted with  1 M 
acetic acid. The eluants from both immunoabsorbents were tested in ELISA for 
binding to PC-BSA and to T 15. Similar binding to T 15 and PC-BSA of affinity- 
purified  11E7-1  hybridoma as well as the  11E7-1  culture supernatant  (Fig.  I) 
was observed (data not shown). 
Specificity of 11E7-l.  11E7-1  supernatant  was  added  to  plates  coated  with 
different PC-binding antibodies and non-PC-binding control antibodies. As seen 
in  Fig.  2,  three  patterns  are  observed.  11E7-1  binds  best to a  group of three 
antibodies,  T15,  HPCG14,  and  MOPC  603;  the  binding  to  HPCG12  and 
HPCGll,  both  T15 +  PC  hybridomas,  is  lower,  while  no  binding  to  M167, 
MOPC511,  HPCG13  (M167  idiotype),  and  MOPC460  (DNP-binding)  is  ob- 
tained. 
To further analyze the fine specificity of the 11E7-1 binding to PC antibodies, 
inhibition  with PC and analogs was performed in a  direct-binding ELISA using 
enzyme-labeled 11E7-1. In Table I, the concentrations of inhibitors giving 50% 
inhibition (ID.~0) of 11E7-1 binding are shown. PC and glycerophosphorylcholine 
are  by far the  best inhibitors,  followed by choline,  which is  ~1,000  times  less 
effective. This inhibition pattern  is reminiscent of the hapten specificity of T15 
and HOPC8 described earlier (14). In Table I, the  11E7-1  binding to insolubil- 
ized 11E7-1 is shown together with the IDa0, using PC and analogs. The observed 
11E7-1 self-binding in Table I will be further examined in the following section. 790  IMMUNOGLOBULIN  WITH  COMPLEMENTARY  PARATOPE  AND  ID1OTOPE 
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FIGURE 2,  Antiidiotype activity of l 1E7-1. The assays were performed in a similar manner 
as in Fig. 1, except the plates were coated with T 15, H PCG14, M603, M511, M 167, M460, 
HPCG12, HPCG13, and HPCG11. 
TABLE  I 
Fine Specificity of Antiidiotype Binding of 1 IE7-1: Inhibition of 
Enzyme-coupled 11E7-1 Binding to Various Antibodies 
by PC Analogs 
Plates coated with:* 
IDs0 (mM) of 11E7-1 binding by: 
Choline  GPC  PC 
T15  1.5  0.07  0.007 
HPCG14  1.3  0.03  0.002 
M603  1.9  0.02  0.006 
11E7-1  1,1  0.005  0.001 
* Microtiter plates were coated for 18 h at 4°C with 2 #g]ml of different 
antibodies, and then incubated with 25 ng of enzyme-coupled 11E7-1 
for  18  h  at  4°C  in  the  presence of different concentrations of PC 
analogs. 
Self-binding  of  llE7-1.  The  results  presented  so  far  suggest  that  llE7-1 
expresses both a  paratope  site for PC and an internal image idiotope of the PC 
hapten.  If  so,  we  should  be  able  to  detect  self-binding  of  l lE7-1  or  self- 
aggregation.  To  test  for  self-binding, affinity-purified, enzyme-labeled  1 1E7-1 
was added to plates coated with  1 1E7-1, T15,  or M167.  The  data shown in Fig. 
3  demonstrates  that  lIE7-1  binds  to  T15  and  to  itself,  but  not  to  M167. 
Furthermore,  self-binding to 1 1 E7-1 was completely inhibited by PC and analogs, 
as shown  in Table  I. 
The  binding specificity of  1 1E7-1  was  further  examined  in  RIA  and  immu- 
noblotting.  1 1 E7-1  was iodinated and allowed to bind to insolubilized 1 1 E7-1, a KANG  AND  KOHLER  791 
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FIGURE 3.  ! 1E7-1 is self-binding. Microtiter plates were coated for 18 h with 100 #l/well of 
11E7-1  or T15 (2 #g/ml) inPBS, washed three times, and incubated for 1 h with 1% BSA in 
PBS. After washing three times, enzyme-coupled 1 IE7-1 in 1% BSA/0.05% Tween 20/borate- 
buffered saline solution was added.  After washing three times, color was developed with 
substrate, and the OD at 405 nm was measured. 
TABLE  II 
Specificity of Binding of '2~I-11E7-1 
Plates coated 
with:*  I sotypes 
Binding* of 1251-11E7-1 (cpm) 
Without PC  With PC (10  -3 M) 
llE7-1  gK  10,080 ±  315  136 +  28 
4F1  #K  125  ±  16  100 ±  8 
T15  c~K  11,157 ±  862  111  ±  34 
M315  aX  289 ±  18  108 ±  14 
F6-3  "tl~  13,069 ±  735  12,972 ±  466 
PCT-BSA  --  13,769 ±  276  119 +  10 
* Microtiter plates were coated for 18 h at 4°C with 10 #g]ml of 11E7-1, 
4F 1, T 15, M 315, F6-3, or 2 #g/ml of PCT-BSA, then incubated with 10 
ng of 1251-11E7-1 (20,000 cpm) for 18 h at 4°C in the absence of PC or 
3  in the presence of PC (10-  M). 
* Binding is expressed as mean ±  SD ofcpm (n =  4). 
panel of other antibodies, and to PC-BSA. The results in Table II confirm data 
obtained  with  ELISA.  4F1  is  an  unrelated  hybridoma  that  has  specificity for 
M167 (15). 
Iodinated  11E7-1  binds strongly to plates coated with  11E7-1, T 15, F6-3 (an 
anti-T15  hybridoma)  (16),  and  PC-BSA at >50%  of added  total  counts.  The 
binding to 11E7-1, T 15, and PC-BSA is completely inhibited by free PC, while 
the binding to F6-3 is not. To confirm these results from the RIA and ELISA, 
iodinated  l lE7-1  was  used  in  immunob|otting  (see  Fig.  4).  Labelled  l lE7-1 
reacts with T15,  11E7-1, F6-3, and PC-BSA, but not with MOPC315 and 4F1. 
Blotting in  the presence  of 10  -~  M  PC is inhibited for  llE7-1,  T15,  and  PC- 
BSA but not for F6-3. No binding is seen to 4F1 and MOPC315. These blotting 
patterns are in complete agreement with the data obtained in ELISA and RIA. 792  IMMUNOGLOBULIN  WITH  COMPLEMENTARY  PARATOPE  AND  IDIOTOPE 
FIGURE 4.  PC inhibits 11E7-1  binding to  11E7-1, T15, and PC-BSA. Two identical nitro- 
cellulose sheets were loaded  with  5  /zl  of various antibodies (1  mg/ml) and  PCT-BSA (0.2 
mg/ml), dried, and blocked for  1 h  with  5%  BSA  in  50  mM  Tris.  The sheets were then 
incubated for 3 h  with 5% BSA in Tris containing l~I-labelled 11E7-1  (10 s cpm/ml), in the 
absence (A) or presence of 10 -s M PC (B). The sheets were washed extensively and exposed 
to Kodak XAR-5 film at -70°C for 3 h. The F6-3 was used as a non-PC-inhibitable control. 
Expression ofT15 Idiotype by 11E7-1.  To evaluate the idiotype family relation- 
ship of the PC-binding  11E7-1,  the  11E7-1  binding to the anti-T15 mAb F6-3 
(16) was determined. As already discussed, 11E7-1  binds to insolubilized F6-3 in 
RIA  and  irnmunoblotting  (see  Table  II  and  Fig.  4).  F6-3  is  a  T15-specific 
antiidiotypic antibody that  does  not recognize the idiotope related to  the  PC 
paratope.  The  binding  of F6-3  to  l lE7-1  has  the  same  characteristics as  its 
binding to T15.  It is not inhibited by free PC (see Table II and Fig. 4).  These 
results indicate that 11E7-1  expresses a classical  T15 idiotope, and suggests that 
11E7-1  belongs  to the T15  idiotype family. We are presently investigating to 
which VH and VL gene families 11E7-1  belongs. 
Discussion 
The first critical question regarding the dual specificity of 11E7-1  concerns 
the  monoclonality of the  hybridoma.  11E7-1  was  recloned twice  by  limiting 
dilution. The cell number was plated each time at 0.3 cell/well, which excludes 
multiclonality at  0.9984  probability.  Additional  evidence for monoclonality is 
the stability of the dual binding properties over >7 mo of passage. 
The  question  of whether  l lE7-1  consists  of a  mixed  molecule cannot  be 
answered  by  serological  and  immunological  techniques,  but  will  have  to  be 
addressed by isolating and/or sequencing the Vn and  VL genes.  These studies 
are underway. Regardless of the answer to the question of mixed Ig molecules KANG AND KOHLER  793 
in 11E7-1, the results deserve to be discussed with regard to the idiotype network 
(16), to structural  consideration on the Ig molecules (17,  18), to a possible role 
in autoimmunity (19), and to the design of idiotype vaccines (20). 
The coexpression of complementary paratope and idiotope sites on the same 
molecule has some important ramifications for the topography of idiotopes and 
paratopes. According to the classical view, the binding site of an antibody resides 
in distinct domain of the molecule, which is characterized by a pocket, groove, 
or cleft. This  model is supported by x-ray crystallographic data of several Fab 
fragments,  which all have a  concave surface area for harboring  the hapten  or 
antigen.  This view might be adequate for antihapten  antibodies,  but has to be 
modified to account for antibodies binding to protein antigens. Recently, models 
of antibody-antigen complexes (21) were discussed that involve rather large and 
flat areas of the antibody,  making  multiple  contacts with the antigen  surface. 
Thus, not all paratopes must be pocket-like structures. 
In support of a nonpocket domain, a recent report by Schiffer and colleagues 
(16) shows a different configuration of the antibody structure.  The Loc ~ chain 
dimer of Schiffer has, in place of the typical pocket, a protrusion that closes the 
antigen-binding cleft. By virtue of having a protrusion instead of a pocket, Loc 
becomes a model for an idiotope-presenting structure. One could speculate that 
the  11ET-1  structure is a hybrid between a pocket and a protrusion model. On 
the  other  hand,  the  simultaneous  expression  of complementary  paratope  and 
idiotope makes a  strong argument for the segregated topographical  location of 
paratopes  and  idiotopes.  This  supports  the  notion  of distinct  paratopic  and 
idiotopic minidomains (6). However, in a functional sense, the distinction between 
paratope and idiotope becomes blurred. There is, a  priori,  no functional superi- 
ority  of the  PC  binding  site  over the  PC  internal  image,  as  both  participate 
equally in the regulation of the immune network (22). 
The properties of 11E7-1  are similar but distinct from the kind of molecule 
described as epibody by Bona et al.  (7) and by Chen  et al.  (8).  These authors 
have characterized an antiidiotype antibody as an epibody, which reacts not only 
with  an  idiotope on  a  monoclonal  human  anti-lgG  autoantibody (rheumatoid 
factor,  RF),  but also with  the  Fc fragment  of human  IgG.  These  results also 
strongly suggest that  an  epibody can  recognize  shared determinants  on the  L 
chain of human RF and human IgG resulting from the Ser-Ser-Ser sequence. In 
contrast  to  the  epibody  described  by  Bona  et  ai.  (7),  the  l lE7-1  molecule 
expresses the idiotypic determinant  for its own paratope. Thus,  11E7-1  exhibits 
self-binding activity. Accordingly, we propose the term autobody to specify the 
potential for self-binding. 
The evaluation of the  11E7-1  properties was greatly facilitated by using the 
small  hapten  PC  as  inhibitor  for  the  binding  activities  of  l lE7-1.  Free  PC 
inhibited both binding functions of 11E7-1, the binding as anti-PC antibody and 
the expression of the internal  PC antigen image. These inhibition data produce 
a clear pattern demonstrating  the dual functionality of 11E7-1.  If PC is used as 
competitive inhibitor of 11E7-1 self-binding, we cannot identify the site of action 
of PC.  In  these  inhibition  experiments,  insolubilized  11E7-1  was coincubated 
with  PC and labeled  11E7-1.  In another experiment,  insolubilized  11E7-1  and 
insolubilized T15 were first incubated with  PC for  18 h.  The plates were then 794  IMMUNOGLOBULIN  WITH  COMPLEMENTARY  PARATOPE  AND  IDIOTOPE 
washed to remove unbound PC.  Radiolabeled  11E7-1  was added for 4  h, and 
the bound radioactivity was measured. The binding of labeled 11E7-1  to T15, 
prereacted with PC,  was >80%  inhibited.  This shows that the PC paratope of 
T15  is  the  target  for binding  by  l lE7-1.  Binding of labeled  llE7-1  to  PC- 
preincubated, insolubilized 11E7-1  was only inhibited by 33% (data not shown). 
This  indicates  that,  after the paratope  of l lE7-1  has  been  occupied by  PC, 
another site on the insolubilized I 1E7-1 is still available for 11E7-1  binding. This 
site is operationally defined as the internal image of PC. These results support 
the model in which 11E7-1  self-binding involves two sites of interaction, which 
can be experimentally distinguished. 
The meaning of a dual-function antibody within the immune network can at 
this  time only be  the subject of speculation. At  face value,  the expression of 
internal  antigen  and  complementary paratope  constitutes  a  mininetwork  or 
closed feedback loop. Biologically, such an antibody may be the product of an 
aberrant clone, and we expect that such a  clone would be eliminated by the 
surveillance of the immune network. In this view,  11E7-1  represents a shorted 
regulatory circuit  without  any consequences for  the  stability  of the  immune 
network balance. 
An important issue in the discussion of the biological implication of antibodies 
with complementary relations of idiotopes and paratopes is the potential for self- 
binding. We attempted to find soluble complexes of purified 11E7-1, but failed. 
Evidently,  11E7-1  does not form self-aggregates in solution, but shows its self- 
affinity only after adsorption to surfaces. This property of self-binding revealed 
only after adsorption could be activated if 11E7-1  has attached to a PC-presenting 
infectious organism, such as after infection with Streptococcus pneumoniae (23). 
Having bound a PC antigen, 11E7-1  now can bind other 11E7-1  molecules, thus 
enforcing the biological defense mechanism and at the same time acting as buffer 
for antiidiotypic suppressive mechanisms. 
Regardless of the role of a dual function antibody in the immune network, an 
antibody with such unique properties might be involved in mechanisms under- 
lying autoimmune  reactions  (9).  Excessive  biosynthesis  of a  self-aggregating 
antibody with specificity for self antigens could lead to severe immune complex 
deposits in critical tissues. Characteristic for such kinds of autoimmune deposits 
would be the lack of nominal antigen material in the deposits. 
Finally, the properties of 11E7-1  might help to advance the rational design of 
idiotype vaccines (20).  Idiotype vaccines modeled after the autobody model (9) 
would transfer immediate passive immunity via its  antibody quality, and long- 
term active immunity by virtue of being an antigen image. Further biological 
and  structural  studies  on  11E7-1  are  needed  to  address  more  decisively its 
possible use as a supervaccine. 
Summary 
A hybridoma antibody (I IE7ol) was isolated from a myeloma fusion with nu/nu 
BALB/c immunized against the T15  idiotype. This IgM antibody exhibited a 
dual specificity, binding both to PC and to anti-PC antibodies from two idiotype 
families. Binding to PC and anti-PC antibodies are completely inhibited by PC 
analogs.  Furthermore, the hybridoma antibody binds  to itself. Self-binding is KANG AND  KOHLER  795 
also inhibited by PC analogs. From these data, we suggest that 11E7-1 hybridoma 
antibody has a PC-specific paratope site, and at same time expresses the internal 
PC antigen idiotope. The term autobody is proposed to signify its self-binding 
and potential role in autoimmunity. Autobodies may have a  unique role in the 
network  of immune  system.  Furthermore,  it  may  be  a  model  for  designing 
idiotype vaccines. 
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